Drugs / ONO-7428
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06816108 | Apr 2025 → Jul 2029 expected | non-small cell lung carcinoma | Ono Pharmaceutical Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ONO-7428 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06816108 ↗ |